Open Market Through Stock Exchange | ₹11.60 Crores | Listing at BSE | Wed, Dec 14, 2022 - Fri, Mar 24, 2023
Jenburkt Pharmaceuticals Ltd Buyback is a tender offer for the repurchase of up to equity shares at a buyback price of ₹702 per share with a face value of ₹10 per share, aggregating to ₹11.60 crores.
The buyback opens on Dec 14, 2022 and closes on Mar 24, 2023.
Dam Capital Advisors Ltd. is the Manager to the Buyback and Bigshare Services Pvt.Ltd. is the Registrar and DAM Capital Advisors Limited is the Registered Broker to the Buyback.
Investors are advised to refer to the Jenburkt Pharmaceuticals Ltd Letter of Offer for detailed information, including eligibility criteria, entitlement ratio, acceptance methodology, and tax implications.
Offer Opening Date
Wed, Dec 14, 2022
Offer Closing Date
Fri, Mar 24, 2023
Buyback Price
₹702 per share
Record Date
[.]
| Period Ended | Total Revenue | Profit After Tax | Net Worth | Total Borrowing |
|---|---|---|---|---|
| 31-Mar-20 | 123.11 | 14.87 | 82.34 | 5.18 |
| 31-Mar-21 | 113.6 | 16.5 | 98.85 | 5.07 |
| 31-Mar-22 | 128.93 | 22.3 | 116.46 | 6.76 |
| Amount in ₹ Crore | ||||
Jenburkt Pharmaceuticals Ltd manufactures and markets pharmaceutical formulations in India and internationally across 13 countries. The company has over 850+ committed team members across functions pan-India, the company promote all the 85 brands across 100,000+ doctors regularly.
The company has more than 1,000 stockists and the company's reach extends to 400,000+ pharmacies across the globe. The company's products are also being exported to 13 countries globally.
The company has Research & Development unit, duly approved by the Ministry of Science & Technology, Government of India, has been set up to develop finished formulations in the therapeutic areas of Geriatrics, Diabetology, Pain management and Neutraceuticals.
| Month | High Price | Low Price | Average Price |
|---|---|---|---|
| Nov-2022 | 645.15 | 572.00 | 590.12 |
| Oct-2022 | 577.25 | 548.65 | 563.91 |
| Sep-2022 | 605.95 | 535.70 | 581.48 |
The buyback is being undertaken for the following reason:
Jenburkt Pharmaceuticals Ltd
Nirmala Apartments, 93,
J. P. Road, Andheri (W),
Mumbai 400058,
Mumbai, Maharashtra, 400058
Lead Manager(s)
Registered Broker
The Jenburkt Pharmaceuticals Buyback opens on December 14, 2022, and closes on March 24, 2023.
The Jenburkt Pharmaceuticals Buyback is a Open Market Through Stock Exchange.
Jenburkt Pharmaceuticals Buyback Schedule
| Buyback Opening Date | December 14, 2022 |
| Buyback Closing Date | March 24, 2023 |
| Last date for acceptance of shares | Upon relevant pay-out by the Stock exchange |
The Jenburkt Pharmaceuticals Buyback is being offered at Rs ₹702 per share.
There is no ratio applicable in case of open market offer through stock exchange mechanism.
The Jenburkt Pharmaceuticals Buyback has announced a buyback for an aggregate amount of not more than Rs. ₹11.60 Crores with pricing of Rs. ₹702 per share.
The buyback is being undertaken for the following reason:
Any equity shareholder holding the shares in Demat form can participate in the buyback offer through their stockbroker. The physical shareholder can participate only once the shares get converted into a Dematerialized form.
The shareholder needs to inform their broker on the details of the Equity shares they wish to sell. The broker will place a sell order whenever the company places a buy order for the buyback. The trade would get executed at the offer price or lesser only when the price offered by the shareholder matches with the buy order placed by the company.
The Jenburkt Pharmaceuticals Buyback offers an opportunity for the shareholders to exit their positions at a premium price. In case you stay invested you would have an increased percentage of shareholding in the company and improved earnings per share. Thus, one should understand the company fundamentals along with one's need, goals, and risk appetite to decide if one wants to stay invested or participate in the buyback offer.
